Search Results - "SYCHEV, D. A."

Refine Results
  1. 1
  2. 2
  3. 3

    Comparative clinical and economic evaluation of pharmacogenetic testing application for dabigatran in patients with atrial fibrillation by Abdullaev, Sh P, Mirzaev, K B, Sychev, D A

    Published in Terapevtic̆eskii arhiv (15-08-2019)
    “…Aim. To evaluate the clinical and economic feasibility of pharmacogenetic testing (PGT) for dabigataran etexilate administration in the treatment of atrial…”
    Get full text
    Journal Article
  4. 4

    Micro-RNA as a new biomarker of activity of the cytochrome system P-450: significance for predicting the antiplatelet action of P2Y12 receptor inhibitors by Rytkin, E I, Mirzaev, K B, Bure, I V, Sychev, D A

    Published in Terapevtic̆eskii arhiv (15-08-2019)
    “…MicroRNAs are short non - coding RNAs that correlate with the levels of platelet activation which can be utilized as a biomarker when guiding P2Y12 inhibitors…”
    Get full text
    Journal Article
  5. 5

    The pharmacogenetics of hypoglycemia and the glycemic variability at the patients ith type 2 diabetes mellitus by Chernikova, N A, Kamynina, L L, Ametov, A S, Sychev, D A, Grishina, E A, Ryzhikova, K A

    Published in Terapevtic̆eskii arhiv (24-11-2020)
    “…To investigate the link between the hypoglycemia (registrated accurately by the professional Continuous Glucose Monitoring CGM; severe hypoglycemia at home)…”
    Get full text
    Journal Article
  6. 6

    Effects of CYP2D6 activity on the efficacy and safety of mirtazapine in patients with depressive disorders and comorbid alcohol use disorder by Zastrozhin, M S, Skryabin, V Y, Smirnov, V V, Grishina, E A, Ryzhikova, K A, Chumakov, E M, Bryun, E A, Sychev, D A

    “…The objective of the study was to investigate the effects of CYP2D6 activity on the efficacy and safety of mirtazapine in patients with depressive disorders…”
    Get more information
    Journal Article
  7. 7

    Results of decision support system implementation for prescribing anticoagulants to patients with atrial fibrillation in hospital by Chernov, A A, Kleymenova, E B, Sychev, D A, Yashina, L P, Nigmatkulova, M D, Otdelenov, V A, Payushchik, S A

    Published in Terapevtic̆eskii arhiv (03-09-2020)
    “…In 819% of patients with atrial fibrillation (AF) with anticoagulant therapy (ACT), hemorrhagic complications occur, including due to excess doses of AC. At…”
    Get full text
    Journal Article
  8. 8

    Genetic features of a patient may influence the efficacy and safety profile of a medicinal product by Sychev, D. A.

    “…Identification of the genetic features that determine a patient’s individual response to a medicinal product and provision of this information to a doctor…”
    Get full text
    Journal Article
  9. 9

    Review of the book “Practical issues of rational antibacterial therapy” by Sychev, D. A.

    “…In 2023, the book “Practical Issues of Rational Antibacterial Therapy” under general ed. Yarovoy SK, Khokhlov AL, was published. This monograph is devoted to…”
    Get full text
    Journal Article
  10. 10
  11. 11

    The frequency of CYP2C19 genetic polymorphisms in Russian patients with peptic ulcers treated with proton pump inhibitors by Sychev, D A, Denisenko, N P, Sizova, Z M, Grachev, A V, Velikolug, K A

    Published in Pharmacogenomics and personalized medicine (01-01-2015)
    “…Proton pump inhibitors, which are widely used as acid-inhibitory agents for the treatment of peptic ulcers, are mainly metabolized by 2C19 isoenzyme of…”
    Get full text
    Journal Article
  12. 12

    Pharmacogenetics of alcohol addiction: current perspectives by Zastrozhin, M S, Skryabin, V Yu, Miroshkin, S S, Bryun, E A, Sychev, D A

    Published in Application of clinical genetics (01-01-2019)
    “…Genetics of alcohol addiction is currently a contradictive and complex field, where data in the most studies reflect methods' limitations rather than…”
    Get full text
    Journal Article
  13. 13

    Polypragmasy: A clinical pharmacologist's view by Sychev, D A, Otdelеnov, V A, Krasnova, N M, Ilyina, E S

    Published in Terapevtic̆eskii arhiv (01-01-2016)
    “…In the modern world, there is a rapid advance in the design and clinical introduction of a huge number of drugs that are able to cure a patient or to improve…”
    Get full text
    Journal Article
  14. 14

    Use of pharmacogenetic testing to prevent adverse drug reactions during statin therapy by Rumyantsev, N A, Kukes, V G, Kazakov, R E, Rumyantsev, A A, Sychev, D A

    Published in Terapevtic̆eskii arhiv (01-01-2017)
    “…The number of patients receiving statins increases every year and due to the fact that they should take statins during their lives, the problem of their safety…”
    Get full text
    Journal Article
  15. 15

    Impact of pharmacogenetic testing on the risk of bleedings and excessive hypocoagulation episodes in the use of warfarin: the first meta-analysis of Russian prospective studies by Sychev, D A, Ivashchenko, D V, Rusin, I V

    Published in Terapevtic̆eskii arhiv (01-01-2014)
    “…To perform a meta-analysis of Russian prospective studies comparing the pharmacogenetic versus conventional warfarin dosing procedures. Publications were…”
    Get full text
    Journal Article
  16. 16

    Lattice Study of the Equation of State of a Rotating Gluon Plasma by Braguta, V. V., Kudrov, I. E., Roenko, A. A., Sychev, D. A., Chernodub, M. N.

    Published in JETP letters (01-05-2023)
    “…The effect of uniform rotation on the equation of state of gluodynamics has been studied in lattice simulation. To this end, the system has been considered in…”
    Get full text
    Journal Article
  17. 17

    Information Security in the Automated Production Control System at PAO Koks by Malyshenko, V. V., Sychev, D. A.

    Published in Coke and chemistry (New York, N.Y.) (01-03-2024)
    “…Information security in the automated production control system at PAO Koks is discussed. Organizational and engineering aspects of security required to ensure…”
    Get full text
    Journal Article
  18. 18

    Clinical and pharmacological technologies of personalized medicine: what now and what will happen? by Sychev, D. A.

    “…«Omic» biomarkers are promising tools for personalizing pharmacotherapy, including and mental illness because allow predicting an individual profile of the…”
    Get full text
    Journal Article
  19. 19

    Optimizing the prophylaxis of hospital-acquired deep vein thrombosis and pulmonary thromboembolism by Nazarenko, G I, Kleymenova, E B, Payushchik, S A, Otdelеnov, V A, Sychev, D A

    Published in Terapevtic̆eskii arhiv (01-01-2016)
    “…To reduce the number of preventable hospital-acquired venous thromboembolic events (HA-VTE) and to improve the quality of VTE prophylaxis at multiprofile…”
    Get full text
    Journal Article
  20. 20

    Antibiotic-Associated Drug-Induced Liver Injury in Critically Ill Children: A Prospective Observational Study by Vlasova, A. V., Shubina, Yu. F., Sychev, D. A.

    “…INTRODUCTION.  Drug-induced liver injury (DILI) is associated, among other things, with the use of antibiotics. Children with DILI are at risk of acute liver…”
    Get full text
    Journal Article